|Bid||0.36 x 0|
|Ask||0.40 x 0|
|Day's Range||0.37 - 0.38|
|52 Week Range||0.35 - 4.90|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
SAN DIEGO, March 16, 2018-- TearLab Corporation today announced that it has applied and received approval for a voluntary delisting of its common stock from the Toronto Stock Exchange in Canada. The delisting ...
SAN DIEGO, March 02, 2018-- TearLab Corporation today reported its consolidated financial results for the fourth quarter and twelve months ended December 31, 2017. All dollar amounts are expressed in U.S. ...
SAN DIEGO, Feb. 28, 2018-- TearLab Corporation today announced that it plans to launch the TearLab Osmolarity System at the 2018 Simpósio Internacional Moacyr Álvaro Annual Meeting, being held March 1-3, ...
NEW YORK, NY / ACCESSWIRE / February 23, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...
SAN DIEGO, Feb. 14, 2018-- TearLab Corporation today announced its plans to appeal a recent ruling from the Federal Court of Canada related to its single Canadian patent. TearLab initiated the lawsuit ...
SAN DIEGO, Jan. 04, 2018-- TearLab Corporation today announced that it has submitted a 510 application to the U.S. Food and Drug Administration for the potential clearance of its TearLab Discovery™ Platform, ...
Zacks.com featured highlights include MINDBODY, TearLab, Sunesis Pharmaceuticals, Children's Place, Franklin Electric